Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review
  • Published:

Animal models of erectile dysfunction (ED): potential utility of non-human primates as a model of atherosclerosis-induced vascular ED

International Journal of Impotence Research volume 24, pages 91–100 (2012)Cite this article

Abstract

Erectile dysfunction (ED) is a prevalent medical condition affecting 18 million men and their sexual partners in the United States alone. In the majority of patients, ED is related to alterations in the flow of blood to or from the penis. Undeniably, significant progress has been made in understanding the multifactorial mechanisms that modulate erectile capacity and predispose one to ED, and this, in turn, has led to the availability of more effective treatment options. Nonetheless, all current therapies have untoward side effects, and moreover, there are still no satisfactory treatments for many patients with ED. Further enhancements in the treatment of ED would logically result from both early intervention and more detailed mechanistic insight into the characteristics of the disease process per se. This fact underscores the importance of improved understanding of the initiation, development and progression of ED. However, to do so requires longitudinal studies on animal models that more closely approximate the corresponding clinical features and time course of human disease. The goal of this report is twofold. First, to provide a brief general overview of the applicability of commonly used animal models for the study of ED. The second and primary goal is to highlight the scientific rationale for using non-human primates to evaluate the impact of atherosclerosis-induced vascular disease on the penile and systemic circulatory systems. This latter goal seems especially relevant in light of the recent literature documenting a link between ED and systemic vascular disease, a finding that has major implications in an aging US male population consuming a high fat diet.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Impotence. NIH Consensus Statement 10, 1992; 1–33.

  2. Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, McKinlay JB . Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol 1994; 151: 54–61.

    Article  CAS  PubMed  Google Scholar 

  3. Bacon CG, Mittleman MA, Kawachi I, Giovannucci E, Glasser DB, Rimm EB . Sexual function in men older than 50 years of age: results from the health professionals follow-up study. Ann Intern Med 2003; 139: 161–168.

    PubMed  Google Scholar 

  4. Montorsi F, Adaikan G, Becher E, Giuliano F, Khoury S, Lue TF et al. Summary of the recommendations on sexual dysfunctions in men. J Sex Med 2010; 7: 3572–3588.

    PubMed  Google Scholar 

  5. Goldstein I . Male sexual circuitry. Working Group for the Study of Central Mechanisms in Erectile Dysfunction. Sci Am 2000; 283: 70–75.

    CAS  PubMed  Google Scholar 

  6. Gratzke C, Angulo J, Chitaley K, Dai YT, Kim NN, Paick JS et al. Anatomy, physiology, and pathophysiology of erectile dysfunction. J Sex Med 2010; 7 (1 Part 2): 445–475, Review.

    CAS  PubMed  Google Scholar 

  7. Burnett AL, Goldstein I, Andersson KE, Argiolas A, Christ G, Park K et al. Future sexual medicine physiological treatment targets. J Sex Med 2010; 7: 3269–3304.

    CAS  PubMed  Google Scholar 

  8. Andersson KE, Wagner G . Physiology of penile erection. Physiol Rev 1995; 75: 191–236.

    CAS  PubMed  Google Scholar 

  9. Andersson KE . Erectile physiological and pathophysiological pathways involved in erectile dysfunction. J Urol 2003; 170 (2 Part 2): S6–S13.

    PubMed  Google Scholar 

  10. Christ GJ, Lue T . Physiology and biochemistry of erections. Endocrine 2004; 23: 93–100.

    CAS  PubMed  Google Scholar 

  11. Lue TF . Erectile dysfunction. N Engl J Med 2000; 342: 1802–1813.

    CAS  PubMed  Google Scholar 

  12. Sáenz de Tejada I, Angulo J, Cellek S, González-Cadavid N, Heaton J, Pickard R et al. J Physiology of erectile function. Sex Med 2004; 1: 254–265.

    Google Scholar 

  13. Gonzalez-Cadavid NF, Rajfer J . Molecular pathophysiology and gene therapy of aging-related erectile dysfunction. Exp Gerontol 2004; 39: 1705–1712.

    CAS  PubMed  Google Scholar 

  14. Eardley I, Donatucci C, Corbin J, El-Meliegy A, Hatzimouratidis K, McVary K et al. Pharmacotherapy for erectile dysfunction. J Sex Med 2010; 7 (1 Part 2): 524–540.

    CAS  PubMed  Google Scholar 

  15. Hatzimouratidis K, Hatzichristou DG . Looking to the future for erectile dysfunction therapies. Drugs 2008; 68: 231–250.

    CAS  PubMed  Google Scholar 

  16. Gur S, Kadowitz PJ, Hellstrom WJ . Exploring the potential of NO-independent stimulators and activators of soluble guanylate cyclase for the medical treatment of erectile dysfunction. Curr Pharm Des 2010; 16: 1619–1633.

    CAS  PubMed  Google Scholar 

  17. Albersen M, Shindel AW, Mwamukonda KB, Lue TF . The future is today: emerging drugs for the treatment of erectile dysfunction. Expert Opin Emerg Drugs 2010; 15: 467–480.

    CAS  PubMed  PubMed Central  Google Scholar 

  18. Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, McKinlay JB . Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol 1994; 151: 54–61.

    CAS  PubMed  Google Scholar 

  19. Althof S . Depression and erectile dysfunction. Men's sexual health consult collection. N Engl J Med 2007; 24: 2472–2481.

    Google Scholar 

  20. Miner MM, Kuritzky L . Erectile dysfunction: a sentinel marker for cardiovascular disease in primary care. Cleve Clin J Med 2007; 74: S30–S37.

    PubMed  Google Scholar 

  21. McMurray G, Casey JH, Naylor AM . Animal models in urological disease and sexual dysfunction. Br J Pharmacol 2006; 147 (Suppl 2): S62–S79.

    CAS  PubMed  PubMed Central  Google Scholar 

  22. Mehta N, Sikka S, Rajasekaran M . Rat as an animal model for male erectile function evaluation in sexual medicine research. J Sex Med 2008; 5: 1278–1283.

    PubMed  Google Scholar 

  23. Giuliano F, Bernabé J, Rampin O, Courtois F, Benoit G, Rousseau JP . Telemetric monitoring of intracavernous pressure in freely moving rats during copulation. J Urol 1994; 152: 1271–1274.

    CAS  PubMed  Google Scholar 

  24. Zhao W, Sato Y, Melman A, Andersson KE, Christ G . Metrics for evaluation of age-related changes in erectile capacity in a rodent model. J Sex Med 2009; 6: 1885–1892.

    PubMed  Google Scholar 

  25. Heaton JP, Varrin SJ, Morales A . The characterization of a bio-assay of erectile function in a rat model. J Urol 1991; 145: 1099–1012.

    CAS  PubMed  Google Scholar 

  26. Song Y, Rajasekaran M . Effect of excitatory amino acid receptor agonists on penile erection after administration into the CA3 hippocampal region in the rat. Urology 2004; 64: 1250–1254.

    PubMed  Google Scholar 

  27. Mills TM, Wiedmeier VT, Stopper VS . Androgen maintenance of erectile function in the rat penis. Biol Reprod 1992; 46: 342–348.

    CAS  PubMed  Google Scholar 

  28. Hsieh JT, Liu SP, Hsieh CH, Cheng JT . An in vivo evaluation of the therapeutic potential of sympatholytic agents on premature ejaculation. BJU Int 1999; 84: 503–506.

    CAS  PubMed  Google Scholar 

  29. Carrier S, Zvara P, Nunes L, Kour NW, Rehman J, Lue TF . Regeneration of nitric oxide synthase containing nerves after cavernous nerve neurotomy in the rat. J Urol 1995; 153: 1722–1727.

    CAS  PubMed  Google Scholar 

  30. Nangle MR, Keast JR . Reduced efficacy of nitrergic neurotransmission exacerbates erectile dysfunction after penile nerve injury despite axonal regeneration. Exp Neurol 2007; 207: 30–41.

    CAS  PubMed  Google Scholar 

  31. Allaf ME, Hoke A, Burnett AL . Erythropoietin promotes the recovery of erectile function following cavernous nerve injury. J Urol 2005; 174: 2060–2064.

    Article  CAS  PubMed  Google Scholar 

  32. Mullerad M, Donohue JF, Li PS, Scardino PT, Mulhall JP . Functional sequelae of cavernous nerve injury in the rat: Is there model dependency. J Sex Med 2006; 3: 77–83.

    PubMed  Google Scholar 

  33. De Young L, Bella A, Howard J, Brock G . Arteriogenic erectile dysfunction alters protein expression within the cavernosal tissue in an animal model. J Sex Med 2005; 2: 199–206.

    CAS  PubMed  Google Scholar 

  34. Chancellor MB, Tirney S, Mattes CE, Tzeng E, Birder LA, Kanai AJ et al. Nitric oxide synthase gene transfer for erectile dysfunction in a rat model. BJU Int 2003; 91: 691–696.

    CAS  PubMed  Google Scholar 

  35. Vernet D, Cai L, Garban H, Babbitt ML, Murray FT, Rajfer J et al. Reduction of penile nitric oxide synthase in diabetic BB/WORdp (type I) and BBZ/WORdp (type II) rats with erectile dysfunction. Endocrinology 1995; 136: 5709–5717.

    CAS  PubMed  Google Scholar 

  36. Bivalacqua TJ, Usta MF, Kendirci M, Pradhan L, Alvarez X, Champion HC et al. Superoxide anion production in the rat penis impairs erectile function in diabetes: influence of in vivo extracellular superoxide dismutase gene therapy. J Sex Med 2005; 2: 187–197.

    CAS  PubMed  Google Scholar 

  37. Wingard C, Fulton D, Husain S . Altered penile vascular reactivity and erection in the Zucker obese/diabetic rat. J Sex Med 2007; 4: 348–362.

    PubMed  Google Scholar 

  38. Zhang X, Filippi S, Morelli A, Luconi M, Donati S, Forti G et al. Testosterone restores diabetes induced erectile dysfunction and sildenafil responsiveness in two distinct animal models of chemical diabetes. J Sex Med 2006; 3: 253–264.

    CAS  PubMed  Google Scholar 

  39. Davila HH, Magee TR, Vernet D, Rajfer J, Gonzalez-Cadavid NF . Gene transfer of inducible nitric oxide synthase complementary DNA regresses the fibrotic plaque in an animal model of Peyronie's disease. Biol Reprod 2004; 71: 1568–1577.

    CAS  PubMed  Google Scholar 

  40. Magee T, Kovanecz I, Davila H, Ferrini M, Cantini L, Vernet D et al. Antisense and short hairpin RNA (shRNA) constructs targeting PIN (protein inhibitor of NOS) ameliorate aging-related erectile dysfunction in the rat. J Sex Med 2007; 4: 633–643.

    CAS  PubMed  Google Scholar 

  41. Rajasekaran M, Kasyan A, Jain A, Kim SW, Monga M . Altered growth factor expression in the aging penis: the Brown-Norway rat model. J Androl 2002; 23: 393–399.

    CAS  PubMed  Google Scholar 

  42. Hannan JL, Blaser MC, Oldfield L, Pang JJ, Adams SM, Pang SC et al. Morphological and functional evidence for the contribution of the pudendal artery in aging-induced erectile dysfunction. J Sex Med 2010; 7: 3373–3384.

    PubMed  Google Scholar 

  43. Christ GJ, Hodges S . Molecular mechanisms of detrusor and corporal myocyte contraction: identifying targets for pharmacotherapy of bladder and erectile dysfunction. Br J Pharmacol 2006; 147 (Suppl 2): S41–S55.

    CAS  PubMed  PubMed Central  Google Scholar 

  44. Christ GJ . K channels as molecular targets for the treatment of erectile dysfunction. J Androl 2002; 23: S10–S19.

    CAS  PubMed  Google Scholar 

  45. Hull EM, Warner RK, Bazzett TJ, Eaton RC, Thompson JT, Scaletta LL . D2/D1 ratio in the medial preoptic area affects copulation of male rats. J Pharmacol Exp Ther 1989; 251: 422–427.

    CAS  PubMed  Google Scholar 

  46. Kita I, Yoshida Y, Nishino S . An activation of parvocellular oxytocinergic neurons in the paraventricular nucleus in oxytocin-induced yawning and penile erection. Neurosci Res 2006; 54: 269–275.

    CAS  PubMed  Google Scholar 

  47. Succu S, Mascia MS, Sanna F, Melis T, Argiolas A, Melis MR . The cannabinoid CB 1 receptor antagonist SR 141716A induces penile erection by increasing extra-cellular glutamic acid in the paraventricular nucleus of male rats. Behav Brain Res 2006; 169: 274–281.

    CAS  PubMed  Google Scholar 

  48. Kimura Y, Naitou Y, Wanibuchi F, Yamaguchi T . 5-HT(2C) receptor activation is a common mechanism on proerectile effects of apomorphine, oxytocin and melanotan-II in rats. Eur J Pharmacol 2008; 589: 157–162.

    CAS  PubMed  Google Scholar 

  49. Villalba N, Stankevicius E, Simonsen U, Prieto D . Rho kinase is involved in Ca2+ entry of rat penile small arteries. Am J Physiol Heart Circ Physiol 2008; 294: H1923–H1932.

    CAS  PubMed  Google Scholar 

  50. Andersson KE . Pharmacology of penile erection. Pharmacol Rev 2001; 53: 417–450.

    CAS  PubMed  Google Scholar 

  51. Andersson KE . Neurophysiology/pharmacology of erection. Int J Impot Res 2001; 13 (3 Suppl): S8–17.

    PubMed  Google Scholar 

  52. Hussain MB, Marshall I . Characterization of alpha1-adrenoceptor subtypes mediating contractions to phenylephrine in rat thoracic aorta, mesenteric artery and pulmonary artery. Br J Pharmacol 1997; 122: 849–858.

    CAS  PubMed  PubMed Central  Google Scholar 

  53. Kendirci M, Salem E, Hellstrom WJ . Dapoxetine, a novel selective serotonin transport inhibitor for the treatment of premature ejaculation. Ther Clin Risk Manag 2007; 3: 277–289.

    CAS  PubMed  PubMed Central  Google Scholar 

  54. Hyun JS, Bivalacqua TJ, Baig MR, Yang DY, Leungwattanakij S, Abdel-Mageed A et al. Localization of peripheral dopamine D1 and D2 receptors in rat corpus cavernosum. BJU Int 2002; 90: 105–112.

    CAS  PubMed  Google Scholar 

  55. d’Emmanuele di Villa Bianca R, Sorrentino R, Roviezzo F, Imbimbo C, Palmieri A, De Dominicis G et al. Peripheral relaxant activity of apomorphine and of a D1 selective receptor agonist on human corpus cavernosum strips. Int J Impot Res 2005; 17: 127–133.

    PubMed  Google Scholar 

  56. Finberg JP, Vardi Y . Inhibitory effect of 5-hydroxytryptamine on penile erectile function in the rat. Br J Pharmacol 1990; 101: 698–702.

    CAS  PubMed  PubMed Central  Google Scholar 

  57. Brugger N, Kim NN, Araldi GL, Traish AM, Palmer SS . Pharmacological and functional characterization of novel EP and DP receptor agonists: DP1 receptor mediates penile erection in multiple species. J Sex Med 2008; 5: 344–356.

    CAS  PubMed  Google Scholar 

  58. Gratzke C, Christ GJ, Stief CG, Andersson KE, Hedlund P . Localization and function of cannabinoid receptors in the corpus cavernosum: basis for modulation of nitric oxide synthase nerve activity. Eur Urol 2010; 57: 342–348.

    CAS  PubMed  Google Scholar 

  59. Sadeghipour H, Ghasemi M, Ebrahimi F, Dehpour AR . Effect of lithium on endothelium-dependent and neurogenic relaxation of rat corpus cavernosum: role of nitric oxide pathway. Nitric Oxide 2007; 16: 54–63.

    CAS  PubMed  Google Scholar 

  60. Bivalacqua TJ, Kendirci M, Champion HC, Hellstrom WJ, Andersson KE, Hedlund P . Dysregulation of cGMP dependent protein kinase 1 (PKG-1) impairs erectile function in diabetic rats: Influence of in vivo gene therapy of PKG1 alpha. BJU Int 2007; 99: 1488–1494.

    CAS  PubMed  Google Scholar 

  61. Magee TR, Ferrini M, Garban HJ, Vernet D, Mitani K, Rajfer J et al. Gene therapy of erectile dysfunction in the rat with penile neuronal nitric oxide synthase. Biol Reprod 2002; 67: 1033–1041.

    PubMed  Google Scholar 

  62. Vignozzi L, Morelli A, Filippi S, Ambrosini S, Mancina R, Luconi M et al. Testosterone regulates RhoA/Rho-kinase signaling in two distinct animal models of chemical diabetes. J Sex Med 2007; 4: 620–630.

    CAS  PubMed  Google Scholar 

  63. Chung SD, Kuo YC, Liu SP, Chang HC, Yu HJ, Hsieh JT . The role of chloride channels in rat corpus cavernosum: in vivo study. J Sex Med 2009; 6: 708–716.

    PubMed  Google Scholar 

  64. Werner ME, Zvara P, Meredith AL, Aldrich RW, Nelson MT . Erectile dysfunction in mice lacking the large-conductance calcium-activated potassium (BK) channel. J Physiol 2005; 567 (Pt 2): 545–556.

    CAS  PubMed  PubMed Central  Google Scholar 

  65. Burgers JK, Nelson RJ, Quinlan DM, Walsh PC . Nerve growth factor, nerve grafts and amniotic membrane grafts restore erectile function in rats. J Urol 1991; 146: 463–468.

    CAS  PubMed  Google Scholar 

  66. Ball RA, Lipton SA, Dreyer EB, Richie JP, Vickers MA . Entubulization repair of severed cavernous nerves in the rat resulting in return of erectile function. J Urol 1992; 148: 211–215.

    CAS  PubMed  Google Scholar 

  67. Burchardt M, Burchardt T, Chen MW, Shabsigh A, de la Taille A, Buttyan R et al. Expression of messenger ribonucleic acid splice variants for vascular endothelial growth factor in the penis of adult rats and humans. Biol Reprod 1999; 60: 398–404.

    CAS  PubMed  Google Scholar 

  68. Garban H, Marquez D, Magee T, Moody J, Rajavashisth T, Rodriguez JA et al. Cloning of rat and human inducible penile nitric oxide synthase. Application for gene therapy of erectile dysfunction. Biol Reprod 1997; 56: 954–963.

    CAS  PubMed  Google Scholar 

  69. Strong TD, Gebska MA, Burnett AL, Champion HC, Bivalacqua TJ . Endothelium-specific gene and stem cell-based therapy for erectile dysfunction. Asian J Androl 2008; 10: 14–1, 22.

    CAS  PubMed  Google Scholar 

  70. Ryu JK, Cho CH, Shin HY, Song SU, Oh SM, Lee M et al. Combined angiopoietin-1 and vascular endothelial growth factor gene transfer restores cavernous angiogenesis and erectile function in a rat model of hypercholesterolemia. Mol Ther 2006; 13: 705–715.

    CAS  PubMed  Google Scholar 

  71. Rogers RS, Graziottin TM, Lin CS, Kan YW, Lue TF . Intracavernosal vascular endothelial growth factor (VEGF) injection and adeno-associated virus-mediated VEGF gene therapy prevent and reverse venogenic erectile dysfunction in rats. Int J Impot Res 2003; 15: 26–37.

    CAS  PubMed  Google Scholar 

  72. Melman A, Biggs G, Davies K, ZhaoW, Tar MT, Christ GJ . Gene transfer with a vector expressing Maxi-K from a smooth muscle-specific promoter restores erectile function in the aging rat. Gene Ther 2008; 15: 364–370.

    CAS  PubMed  Google Scholar 

  73. Christ GJ, Day N, Santizo C, Sato Y, Zhao W, Sclafani T et al. Intracorporal injection of hSlo cDNA restores erectile capacity in STZdiabetic F-344 rats in vivo. Am J Physiol Heart Circ Physiol 2004; 287: H1544–H1553.

    CAS  PubMed  Google Scholar 

  74. Bivalacqua TJ, Champion HC, Abdel-Mageed AB, Kadowitz PJ, Hellstrom WJ . Gene transfer of prepro-calcitonin gene related peptide restores erectile function in the aged rat. Biol Reprod 2001; 65: 1371–1377.

    CAS  PubMed  Google Scholar 

  75. Clarkson TB . Nonhuman primate models of atherosclerosis. Lab Anim Sci 1998; 48: 569–572.

    CAS  PubMed  Google Scholar 

  76. Ziegler MA, Distasi MR, Bills RG, Miller SJ, Alloosh M, Murphy MP et al. Marvels, mysteries, and misconceptions of vascular compensation to peripheral artery occlusion. Microcirculation 2010; 17: 3–20, Review.

    PubMed  PubMed Central  Google Scholar 

  77. Proctor SD, Russell JC . Small animal models of cardiovascular disease: tools for the study of the metabolic syndrome, dyslipidemias and atherosclerosis. J Cardiovasc Pathol 2006; 15: 318–330.

    Google Scholar 

  78. Sezen SF, Burnett AL . Intracavernosal pressure monitoring in mice: responses to electrical stimulation of the cavernous nerve and to intracavernosal drug administration. J Androl 2000; 21: 311–315.

    CAS  PubMed  Google Scholar 

  79. Piao S, Ryu JK, Shin HY, Han JY, Lee HS, Suh JK . The mouse as a model for the study of penile erection: moving towards a smaller animal. Int J Androl 2007; 30: 452–457.

    PubMed  Google Scholar 

  80. Carneiro FS, Sturgis LC, Giachini FR, Carneiro ZN, Lima VV, Wynne BM et al. TNF-alpha knockout mice have increased corpora cavernosa relaxation. J Sex Med 2009; 6: 115–125.

    CAS  PubMed  Google Scholar 

  81. Carneiro FS, Giachini FR, Lima VV, Carneiro ZN, Leite R, Inscho EW et al. Adenosine actions are preserved in corpus cavernosum from obese and type II diabetic db/db mouse. J Sex Med 2008; 5: 1156–1166.

    CAS  PubMed  PubMed Central  Google Scholar 

  82. Mi T, Abbasi S, Zhang H, Uray K, Chunn JL, Xia LW et al. Excess adenosine in murine penile erectile tissues contributes to priapism via A2B adenosine receptor signaling. J Clin Invest 2008; 118: 1491–1501.

    CAS  PubMed  PubMed Central  Google Scholar 

  83. Hurt KJ, Sezen SF, Champion HC, Crone JK, Palese MA, Huang PL et al. Alternatively spliced neuronal nitric oxide synthase mediates penile erection. Proc Natl Acad Sci USA 2006; 103: 3440–3443.

    CAS  PubMed  PubMed Central  Google Scholar 

  84. Burnett AL, Nelson RJ, Calvin DC, Liu JX, Demas GE, Klein SL et al. Nitric oxide-dependent penile erection in mice lacking neuronal nitric oxide synthase. Mol Med 1996; 2: 288–296.

    CAS  PubMed  PubMed Central  Google Scholar 

  85. Kriegsfeld LJ, Demas GE, Huang PL, Burnett AL, Nelson RJ . Ejaculatory abnormalities in mice lacking the gene for endothelial nitric oxide synthase (eNOS). Physiol Behav 1999; 67: 561–566.

    CAS  PubMed  Google Scholar 

  86. Burnett AL, Chang AG, Crone JK, Huang PL, Sezen SE . Noncholinergic penile erection in mice lacking the gene for endothelial nitric oxide synthase. J Androl 2002; 23: 92–97.

    CAS  PubMed  Google Scholar 

  87. Pfeifer A, Klatt P, Massberg S, Ny L, Sausbier M, Hirneiss C et al. Defective smooth muscle regulation in cGMP kinase I-deficient mice. EMBO J 1998; 17: 3045–3051.

    CAS  PubMed  PubMed Central  Google Scholar 

  88. Werner ME, Meredith AL, Aldrich RW, Nelson MT . Hypercontractility and impaired sildenafil relaxations in the BKCa channel deletion model of erectile dysfunction. Am J Physiol Regul Integr Comp Physiol 2008; 295: R181–R188.

    CAS  PubMed  PubMed Central  Google Scholar 

  89. Musicki B, Liu T, Lagoda GA, Strong TD, Sezen SF, Johnson JM et al. Hypercholesterolemia-induced erectile dysfunction: endothelial nitric oxide synthase (eNOS) uncoupling in the mouse penis by NAD(P)H oxidase. J Sex Med 2010; 7: 3023–3032.

    CAS  PubMed  PubMed Central  Google Scholar 

  90. Filippi S, Amerini S, Maggi M, Natali A, Ledda F . Studies on the mechanisms involved in the ATP-induced relaxation in human and rabbit corpus cavernosum. J Urol 1999; 161: 326–331.

    CAS  PubMed  Google Scholar 

  91. Xie D, Findley CM, Greenfield JM, Pippen AM, Kontos CD, Donatucci CF et al. A VEGF trap inhibits the beneficial effect of bFGF on vasoreactivity in corporal tissues of hypercholesterolemic rabbits. J Sex Med 2008; 5: 2069–2078.

    CAS  PubMed  Google Scholar 

  92. Vural IM, Ozturk GS, Sarioglu Y . Functional characterization of nonadrenergic noncholinergic neurotransmitter release via endocannabinoids: an in vitro study in rabbit corpus cavernosum. J Sex Med 2009; 6: 717–729.

    CAS  PubMed  Google Scholar 

  93. Bozkurt NB, Vural IM, Sarioglu Y, Pekiner C . Nicotine potentiates the nitrergic relaxation responses of rabbit corpus cavernosum tissue via nicotinic acetylcholine receptors. Eur J Pharmacol 2007; 558: 172–178.

    CAS  PubMed  Google Scholar 

  94. Morton JS, Daly CJ, Jackson VM, McGrath JC . Alpha(1A)- adrenoceptors mediate contractions to phenylephrine in rabbit penile arteries. Br J Pharmacol 2007; 150: 112–120.

    CAS  PubMed  Google Scholar 

  95. Kim NN, Kim JJ, Hypolite J, García-Díaz JF, Broderick GA, Tornheim K et al. Altered contractility of rabbit penile corpus cavernosum smooth muscle by hypoxia. J Urol 1996; 155: 772–778.

    CAS  PubMed  Google Scholar 

  96. Mumtaz FH, Lau DH, Siddiqui EJ, Thompson CS, Morgan RJ, Mikhailidis DP . Pharmacological properties of endothelin-1 in the rabbit corpus cavernosum. In Vivo 2006; 20: 243–246.

    CAS  PubMed  Google Scholar 

  97. Furukawa K, Nagao K, Ishii N, Uchiyama T . Responses to serotonin (5HT) in isolated corpus cavernosum penis of rabbit. Int J Impot Res 2003; 15: 267–271.

    CAS  PubMed  Google Scholar 

  98. Wu HY, Broderick GA, Suh JK, Hypolite JA, Levin RM . Effects of purines on rabbit corpus cavernosum contractile activity. Int J Impot Res 1993; 5: 161–167.

    CAS  PubMed  Google Scholar 

  99. Morelli A, Chavalmane AK, Filippi S, Fibbi B, Silvestrini E, Sarchielli E et al. Atorvastatin ameliorates sildenafil-induced penile erections in experimental diabetes by inhibiting diabetes-induced RhoA/Rho-kinase signaling hyperactivation. J Sex Med 2009; 6: 91–106.

    CAS  PubMed  Google Scholar 

  100. Zhang Q, Radisavljevic ZM, Siroky MB, Azadzoi KM . Dietary antioxidants improve arteriogenic erectile dysfunction. Int J Androl 2011; 34: 225–235.

    CAS  PubMed  Google Scholar 

  101. Azadzoi KM, Golabek T, Radisavljevic ZM, Yalla SV, Siroky MB . Oxidative stress and neurodegeneration in penile ischaemia. BJU Int 2010; 105: 404–410.

    PubMed  Google Scholar 

  102. Azadzoi KM, Schulman RN, Aviram M, Siroky MB . Oxidative stress in arteriogenic erectile dysfunction: prophylactic role of antioxidants. J Urol 2005; 174: 386–393.

    CAS  PubMed  Google Scholar 

  103. Azadzoi KM, Master TA, Siroky MB . Effect of chronic ischemia on constitutive and inducible nitric oxide synthase expression in erectile tissue. J Androl 2004; 25: 382–388.

    CAS  PubMed  Google Scholar 

  104. Wang T, Soker S, Atala A, Siroky MB, Azadzoi KM . Alterations in angiogenic growth factors and neuronal nitric oxide synthase expression in chronic cavernosal ischemia. Int J Impot Res 2004; 16: 403–411.

    PubMed  Google Scholar 

  105. Kim NN, Dhir V, Azadzoi KM, Traish AM, Flaherty E, Goldstein I . Pilot study of the endothelin-A receptor selective antagonist BMS-193884 for the treatment of erectile dysfunction. J Androl 2002; 23: 76–83.

    CAS  PubMed  Google Scholar 

  106. Azadzoi KM, Krane RJ, Saenz de Tejada I, Goldstein I, Siroky MB . Relative roles of cyclooxygenase and nitric oxide synthase pathways in ischemia-induced increased contraction of cavernosal smooth muscle. J Urol 1999; 161: 1324–1328.

    CAS  PubMed  Google Scholar 

  107. Azadzoi KM, Goldstein I, Siroky MB, Traish AM, Krane RJ, Saenz de Tejada I . Mechanisms of ischemia-induced cavernosal smooth muscle relaxation impairment in a rabbit model of vasculogenic erectile dysfunction. J Urol 1998; 160 (6 Part 1): 2216–2222.

    CAS  PubMed  Google Scholar 

  108. Henry GD, Byrne R, Hunyh TT, Abraham V, Annex BH, Hagen PO et al. Intracavernosal injections of vascular endothelial growth factor protects endothelial dependent corpora cavernosal smooth muscle relaxation in the hypercholesterolemic rabbit: a preliminary study. Int J Impot Res 2000; 12: 334–339.

    CAS  PubMed  Google Scholar 

  109. Dai Q, Silverstein AD, Davies MG, Hagen PO, Donatucci CF, Annex BH . Systemic basic fibroblast growth factor induces favorable histological changes in the corpus cavernosum of hypercholesterolemic rabbits. J Urol 2003; 170: 664–668.

    CAS  PubMed  Google Scholar 

  110. Xie D, Kontos CD, Donatucci CF, Annex BH . Cholesterol feeding reduces vascular endothelial growth factor signaling in rabbit corporal tissues. J Sex Med 2005; 2: 634–640.

    CAS  PubMed  Google Scholar 

  111. Xie D, Pippen AM, Odronic SI, Annex BH, Donatucci CF . Intracavernosal basic fibroblast growth factor improves vasoreactivity in the hypercholesterolemic rabbit. J Sex Med 2006; 3: 223–232.

    CAS  PubMed  Google Scholar 

  112. Xin ZC, Choi YD, Choi HK . The effects of SS-cream and its individual components on rabbit corpus cavernosal muscles. Yonsei Med J 1996; 37: 312–318.

    CAS  PubMed  Google Scholar 

  113. Yoo JJ, Park HJ, Atala A . Tissue-engineering applications for phallic reconstruction. World J Urol 2000; 18: 62–66.

    CAS  PubMed  Google Scholar 

  114. Falke G, Yoo JJ, Kwon TG, Moreland R, Atala A . Formation of corporal tissue architecture in vivo using human cavernosal muscle and endothelial cells seeded on collagen matrices. Tissue Eng 2003; 9: 871–879.

    CAS  PubMed  Google Scholar 

  115. Simonsen U, Prieto D, Hernández M, Sáenz de Tejada I, García-Sacristán A . Prejunctional alpha 2-adrenoceptors inhibit nitrergic neurotransmission in horse penile resistance arteries. J Urol 1997; 157: 2356–2360.

    CAS  PubMed  Google Scholar 

  116. Lue TF, Zeineh SJ, Schmidt RA, Tanagho EA . Neuroanatomy of penile erection: its relevance to iatrogenic impotence. J Urol 1984; 131: 273–280.

    CAS  PubMed  Google Scholar 

  117. Mattiasson A, Andersson KE, Sjögren C . Adrenoceptors and cholinoceptors controlling noradrenaline release from adrenergic nerves in the urethra of rabbit and man. J Urol 1984; 131: 1190–1195.

    CAS  PubMed  Google Scholar 

  118. Andersson PO, Bloom SR, Mellander S . Haemodynamics of pelvic nerve induced penile erection in the dog: possible mediation by vasoactive intestinal polypeptide. J Physiol 1984; 350: 209–224.

    CAS  PubMed  PubMed Central  Google Scholar 

  119. Noto T, Inoue H, Mochida H, Kikkawa K . Role of adenosine and P2 receptors in the penile tumescence in anesthetized dogs. Eur J Pharmacol 2001; 425: 51–55.

    CAS  PubMed  Google Scholar 

  120. Takahashi Y, Ishii N, Lue TF, Tanagho EA . Effects of adenosine on canine penile erection. J Urol 1992; 148: 1323–1325.

    CAS  PubMed  Google Scholar 

  121. Takahashi Y, Aboseif SR, Benard F, Stief CG, Lue TF, Tanagho EA . Effect of intracavernous simultaneous injection of acetylcholine and vasoactive intestinal polypeptide on canine penile erection. J Urol 1992; 148: 446–448.

    CAS  PubMed  Google Scholar 

  122. Cahn D, Melman A, Valcic M, Christ GJ . Forskolin: a promising new adjunct to intracavernous pharmacotherapy. J Urol 1996; 155: 1789–1794.

    CAS  PubMed  Google Scholar 

  123. Trigo-Rocha F, Hsu GL, Donatucci CF, Martinez-Piñeiro L, Lue TF, Tanagho EA . Intracellular mechanism of penile erection in monkeys. Neurourol Urodyn 1994; 13: 71–80.

    CAS  PubMed  Google Scholar 

  124. Giraldi A, Wagner G . Effects of pinacidil upon penile erectile tissue, in vitro and in vivo. Pharmacol Toxicol 1990; 67: 235–238.

    CAS  PubMed  Google Scholar 

  125. Diederichs W, Kaula NF, Lue TF, Tanagho EA . The effect of subatmospheric pressure on the simian penis. J Urol 1989; 142: 1087–1089.

    CAS  PubMed  Google Scholar 

  126. Aboseif SR, Breza J, Bosch RJ, Benard F, Stief CG, Stackl W et al. Local and systemic effects of chronic intracavernous injection of papaverine, prostaglandin E1, and saline in primates. J Urol 1989; 142 (2 Part 1): 403–408.

    CAS  PubMed  Google Scholar 

  127. Mueller SC, Aboseif S, Fahey MR, Lue TF, Tanagho EA . Spinal anesthesia and electroerection in dogs and monkeys. J Urol 1989; 142: 171–175.

    CAS  PubMed  Google Scholar 

  128. Abozeid M, Juenemann KP, Luo JA, Lue TF, Yen TS, Tanagho EA . Chronic papaverine treatment: the effect of repeated injections on the simian erectile response and penile tissue. J Urol 1987; 138: 1263–1266.

    CAS  PubMed  Google Scholar 

  129. Lue TF . The mechanism of penile erection in the monkey. Semin Urol 1986; 4: 217–224.

    CAS  PubMed  Google Scholar 

  130. Adams MR, Kaplan JR, Koritnik DR, Weaver DS, Bond MG . Erectile failure in cynomolgus monkeys with atherosclerosis of the arteries supplying the penis. J Urol 1984; 131: 571–573.

    CAS  PubMed  Google Scholar 

  131. Christ GJ, Andersson KE, Williams K, Zhao W, D’Agostino Jr R, Kaplan J et al. Smooth-muscle-specific gene transfer with the human maxi-K channel improves erectile function and enhances sexual behavior in atherosclerotic cynomolgus monkeys. Eur Urol 2009; 56: 1055–1066.

    CAS  PubMed  Google Scholar 

  132. Faggiotto A, Ross R, Harker L . Studies of hypercholesterolemia in the nonhuman primate. I. Changes that lead to fatty streak formation. Arteriosclerosis 1984; 4: 323–340.

    CAS  PubMed  Google Scholar 

  133. Faggiotto A, Ross R . Studies of hypercholesterolemia in the nonhuman primate. II. Fatty streak conversion to fibrous plaque. Arteriosclerosis 1984; 4: 341–356.

    CAS  PubMed  Google Scholar 

  134. Williams JK, Anthony MS, Clarkson TB . Coronary heart disease in rhesus monkeys with diet-induced coronary artery atherosclerosis. Arch Pathol Lab Med 1991; 115: 784–790.

    CAS  PubMed  Google Scholar 

  135. Register TC, Cann JA, Kaplan JR, Williams JK, Adams MR, Morgan TM et al. Effects of soy isoflavones and conjugated equine estrogens on inflammatory markers in atherosclerotic, ovariectomized monkeys. J Clin Endocrinol Metab 2005; 90: 1734–1740.

    CAS  PubMed  Google Scholar 

  136. Jackson G, Boon N, Eardley I, Kirby M, Dean J, Hackett G et al. Erectile dysfunction and coronary artery disease prediction: evidence-based guidance and consensus. Int J Clin Pract 2010; 64: 848–857.

    CAS  PubMed  Google Scholar 

  137. Gazzaruso C, Coppola A, Giustina A . Erectile dysfunction and coronary artery disease in patients with diabetes. Curr Diabetes Rev 2011; 7: 143–147.

    PubMed  Google Scholar 

  138. Schwartz BG, Kloner RA . Cardiovascular implications of erectile dysfunction. Circulation 2011; 123: e609–e611.

    PubMed  Google Scholar 

  139. Maas R, Schwedhelm E, Albsmeier J, Böger RH . The pathophysiology of erectile dysfunction related to endothelial dysfunction and mediators of vascular function. Vasc Med 2002; 7: 213–225.

    PubMed  Google Scholar 

  140. Kirby M, Jackson G, Betteridge J, Friedli K . Is erectile dysfunction amarker for cardiovascular disease? Int J Clin Pract 2001; 55: 614–618.

    CAS  PubMed  Google Scholar 

  141. Jones RW, Rees RW, Minhas S, Ralph D, Persad RA, Jeremy JY . Oxygen free radicals and the penis. Expert Opin Pharmacother 2002; 3: 889–897.

    CAS  PubMed  Google Scholar 

  142. Lue TF . Erectile dysfunction. N Engl J Med 2000; 342: 1802–1813.

    CAS  PubMed  Google Scholar 

  143. Rehman J, Melman A . Normal anatomy and physiology. In: Mulcahy, JJ (ed). Male Sexual Function. A Guide to Clinical Management, Vol. 201 Humana Press: Towata, NJ, 2001 pp 1–46.

    Google Scholar 

  144. Dakak N, Gilligan DM, Andrews NP, Diodati JG, Panza JA, Schenke WH et al. Peripheral vascular endothelial dysfunction in patients with multiple coronary risk factors (abstract). Circulation 1993; 88: 1–618.

    Google Scholar 

  145. Zeiher AM, Drexler H, Wollschlager H, Just H . Endothelial dysfunction of the coronary microvasculature is associated with coronary blood flow regulation in patients with early atherosclerosis. Circulation 1991; 84: 1984–1992.

    CAS  PubMed  Google Scholar 

  146. McLenachan JM, Vita J, Fish DR, Treasure CB, Cox DA, Ganz P et al. Early evidence of endothelial vasodilator dysfunction at coronary branch points. Circulation 1990; 82: 1169–1173.

    CAS  PubMed  Google Scholar 

  147. Werns SW, Walton JA, Hsia HH, Nabel EG, Sanz ML, Pitt B . Evidence of endothelial dysfunction in angiographically normal coronary arteries of patients with coronary artery disease. Circulation 1989; 79: 287–291.

    CAS  PubMed  Google Scholar 

  148. Katz SD, Biasucci L, Sabba C, Strom JA, Jondeau G, Galvao M et al. Impaired endothelium-mediated vasodilation in the peripheral vasculature of patients with congestive heart failure. J Am Coll Cardiol 1992; 19: 918–925.

    CAS  PubMed  Google Scholar 

  149. Brevetti G, Silvestro A, Schiano V, Chiariello M . Endothelial dysfunction and cardiovascular risk prediction in peripheral arterial disease: additive value of flow-mediated dilation to ankle–brachial pressure index. Circulation 2003; 108: 2093–2098.

    PubMed  Google Scholar 

  150. Chowienczyk PJ, Watts GF, Cockcroft JR, Ritter JM . Impaired endothelium-dependent vasodilation of forearm resistance vessels in hypercholesterolaemia. Lancet 1992; 340: 1430–1432.

    CAS  PubMed  Google Scholar 

  151. Schindler TH, Hornig B, Buser PT, Olschewski M, Magosaki N, Pfisterer M et al. Prognostic value of abnormal vasoreactivity of epicardial coronary arteries to sympathetic stimulation in patients with normal coronary angiograms. Arterioscler Thromb Vasc Biol 2003; 23: 495–501.

    CAS  PubMed  Google Scholar 

  152. Halcox JP, Schenke WH, Zalos G, Mincemoyer R, Prasad A, Waclawiw MA et al. Prognostic value of coronary vascular endothelial dysfunction. Circulation 2002; 106: 653–658.

    PubMed  Google Scholar 

  153. Schachinger V, Britten MB, Zeiher AM . Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. Circulation 2000; 101: 1899–1906.

    CAS  PubMed  Google Scholar 

  154. Billups KL, Bank AJ, Padma-Nathan H, Katz SD, Williams RA . Erectile dysfunction as a harbinger for increased cardiometabolic risk. Int J Impot Res 2008; 20: 236–242.

    CAS  PubMed  Google Scholar 

  155. Hale TM, Hannan JL, Carrier S, deBlois D, Adams MA . Targeting vascular structure for the treatment of sexual dysfunction. J Sex Med 2009; 6 (Suppl 3): 210–220.

    PubMed  Google Scholar 

  156. Prieto D . Physiological regulation of penile arteries and veins. Int J Impot Res 2008; 20: 17–29.

    CAS  PubMed  Google Scholar 

  157. Jackson G . Erectile dysfunction and cardiovascular disease. Int J Clin Pract 1999; 53: 363–368.

    CAS  PubMed  Google Scholar 

  158. O’Kane PD, Jackson G . Erectile dysfunction: is there silent obstructive coronary artery disease? Int J Clin Pract 2001; 55: 219–220.

    PubMed  Google Scholar 

  159. Basar MM, Sargon MF, Basar H, Atan A, Ak F, Celik HH et al. Comparative study between corpus cavernosum-electromyography findings and electron microscopy of cavernosal muscle biopsies in erectile dysfunction patients. Int J Urol 1998; 5: 252–255.

    CAS  PubMed  Google Scholar 

  160. Hobbs FD . Cardiovascular disease: different strategies for primary and secondary prevention? Heart 2004; 90: 1217–1223.

    CAS  PubMed  PubMed Central  Google Scholar 

  161. McLenachan JM, Williams JK, Fish RD, Ganz P, Selwyn AP . Loss of flow-mediated endothelium-dependent dilation occurs early in the development of atherosclerosis. Circulation 1991; 84: 1273–1278.

    CAS  PubMed  Google Scholar 

  162. Cullen P, Rauterberg J, Lorkowski S . The pathogenesis of atherosclerosis. Handb Exp Pharmacol 2005; 170: 3–70.

    CAS  Google Scholar 

  163. Ross R . The pathogenesis of atherosclerosis. In: Braunwald E (ed). Heart Disease: A Textbook of Cardiovascular Medicine. W.B. Saunders Co, Philadelphia, PA, 1988 pp 135–152.

  164. Félétou M, Vanhoutte PM . Endothelial dysfunction: a multifaceted disorder (The Wiggers Award Lecture). Am J Physiol Heart Circ Physiol 2006; 291: H985–H1002.

    PubMed  Google Scholar 

  165. Thomas CM, Smart EJ . Gender as a regulator of atherosclerosis in murine models. Curr Drug Targets 2007; 8: 1172–1180.

    CAS  PubMed  Google Scholar 

  166. Schwenke DC . Gender differences in intima-media permeability to low-density lipoprotein at atherosclerosis-prone aortic sites in rabbits. Lack of effect of 17 beta-estradiol. Arterioscler Thromb Vasc Biol 1997; 17: 2150–2157.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Wake Forest University Institute for Regenerative Medicine, Winston-Salem, NC, USA

    J K Williams, K-E Andersson & G Christ

Authors
  1. J K Williams
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. K-E Andersson
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. G Christ
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to J K Williams.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Williams, J., Andersson, KE. & Christ, G. Animal models of erectile dysfunction (ED): potential utility of non-human primates as a model of atherosclerosis-induced vascular ED. Int J Impot Res 24, 91–100 (2012). https://doi.org/10.1038/ijir.2011.56

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ijir.2011.56

Keywords

Search

Advanced search

Quick links